Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 5:11:285.
doi: 10.3389/fendo.2020.00285. eCollection 2020.

Osteogenic and Chondrogenic Potential of the Supramolecular Aggregate T-LysYal®

Affiliations

Osteogenic and Chondrogenic Potential of the Supramolecular Aggregate T-LysYal®

Adriana Di Benedetto et al. Front Endocrinol (Lausanne). .

Abstract

Hard tissue regeneration represents a challenge for the Regenerative Medicine and Mesenchymal stem cells (MSCs) could be a successful therapeutic strategy. T-LysYal® (T-Lys), a new derivative of Hyaluronic Acid (HA) possessing a superior stability, has already been proved efficient in repairing corneal epithelial cells damaged by dry conditions in vitro. We investigated the regenerative potential of T-Lys in the hard tissues bone and cartilage. We have previously demonstrated that cells isolated from the tooth germ, Dental Bud Stem Cells (DBSCs), differentiate into osteoblast-like cells, representing a promising source of MSCs for bone regeneration. Herewith, we show that T-Lys treatment stimulates the expression of typical osteoblastic markers, such as Runx-2, Collagen I (Col1) and Alkaline Phosphatase (ALP), determining a higher production of mineralized matrix nodules. In addition, we found that T-Lys treatment positively affects αVβ3 integrin expression, key integrin in the osteoblastic commitment, leading to the formation of focal adhesions (FAs). The efficacy of T-Lys was also tested on chondrogenic differentiation starting from human articular chondrocytes (HACs) resulting in an increase of differentiation markers and cell number.

Keywords: bone; cartilage; focal adhesions; mesenchymal stem cells; supramolecular aggregate; tissue regeneration.

PubMed Disclaimer

Figures

Figure 1
Figure 1
T-Lys treatment in DBSCs cultures. (A) Dental bud isolated from a third molar of a healthy patient. Scale bar: 1 cm. (B) Representative phase contrast pictures of DBSCs cultivated in osteogenic medium and stimulated with 0.3% v/v T-Lys (T-Lys) or not (Ctr). Scale bar: 20 μm.
Figure 2
Figure 2
Effects of T-Lys on the expression of osteoblast markers. (A) qPCR performed on DBSCs cultivated with osteogenic medium for 12 days and stimulated with 0.3% v/v T-Lys and Ctr. The graphs show that the treatment significantly increased the expression of the two osteoblast markers Runx-2 and Col1. Expression was normalized to β2microglobulin (B2M). Each graph represents the mean ± SE of 3 independent experiments performed in triplicate. #P < 0.05 compared to Ctr. Statistics: unpaired Student's t-test. (B) Immunoblotting confirmed that the expression of Runx-2 and Col1 protein increased in T-Lys treated cells relative to Ctr cells. Each graph represents the mean OD ± SE of 3 independent experiments performed in triplicate. *P < 0.001 compared to Ctr. Statistics: Unpaired Student's t-test. Representative immunoblots were chosen for the figure. (C) ALP histochemical assay (purple staining) performed on DBSCs maintained in osteogenic conditions for 7 days and stimulated with T-Lys and Ctr. The graph represents the quantification of positive staining as percentage compared to Ctr (§P < 0.01) and is representative for 3 independent experiments performed in quadruplicates. Data are presented as mean ± SE. Student's t-test was used for single comparisons. The wells of a representative experiment were chosen for the figure.
Figure 3
Figure 3
Mineral matrix deposition following T-Lys stimulation and Alizarin Red quantification. (A) Formation of calcium rich deposits in representative phase contrast pictures of DBSCs treated with T-Lys, HA or Ctr for 21 days in osteogenic conditions. Scale bar: 20 μm. (B) Mineral matrix deposition assayed by ARS (red staining). The graph shows the OD quantification of extracted dye from stained cell layers as mean percentage ± SE and is representative for 3 independent experiments performed in quadruplicates. §P < 0.01, *P < 0.001 compared to Ctr; §P < 0.01 compared to HA. Student's t-test was used for single comparisons. The wells of a representative experiment were chosen for the figure.
Figure 4
Figure 4
Subcellular localization of integrin αVβ3. Midsection confocal microscopy images show the expression of integrin αVβ3 (green) detected by the antibody LM609 in cells maintained for 4 days in osteogenic medium and treated with T-Lys and Ctr; picture (A) shows a single cell with integrin distributed in multiple pointed sites in Ctr, while T-Lys treatment induced a different organization of the integrin that appeared strongly augmented and more clustered and localized at the focal adhesion sites (B). Similar distribution is observable in clustered cells (C,D). Images of a representative experiment were chosen for the figure. Scale bar: 10 μm.
Figure 5
Figure 5
Effects of T-Lys on the expression of chondrocyte markers. (A) Representative phase contrast pictures of HACs treated with T-Lys (T-Lys) or not (Ctr) after 3 days (upper panel) and 15 days (lower panel) of culture. T-Lys treatment significantly increased matrix deposition at the expense of a dedifferentiation process after 15 days of culture (lower panel). Scale bar: 20 μm. (B) qPCR performed on chondrocyte pellet cultures cultivated 28 days with chondrogenic medium and stimulated with 0.3% v/v T-Lys and Ctr. The graphs show that the treatment significantly increased the expression of the chondrocyte markers Sox-9 and Col II, while had no effect on the expression of Aggrecan. Expression was normalized to β2microglobulin (B2M). Each graph represents the mean ± SE of 3 independent experiments performed in triplicate. #P < 0.05, *P < 0.001 compared to Ctr. Statistics: unpaired Student's t-test.
Figure 6
Figure 6
Effects of T-Lys on chondrocytes proliferation and tissue growth. (A) Sectioned chondrocyte pellets were captured under optical microscope using a 20X objective lens and analyzed by using Image-J software for morphometric examination of the areas. T-Lys pellet appeared larger than Ctrs. The pictures selected are representative of three different experiments, scale bar: 75 μm. The graph represents the mean ± SE of 3 independent experiments performed in triplicate, *P < 0.001. (B) Deposition of cartilaginous matrix was demonstrated by Safranin O staining and chondrocyte nuclei were counterstained with hematoxylin. The pictures were captured with 40X objective lens, scale bar: 25 μm. The graph represents the mean ± SE of 3 independent experiments performed in triplicate, #P < 0.05. (C) The graph shows a theoretical reconstruction of the pellet thickness where the number of sections obtained was multiplied by the slice thickness (μm).

References

    1. O'Driscoll SW. The healing and regeneration of articular cartilage. J Bone Joint Surg Am. (1998) 80:1795–812. 10.2106/00004623-199812000-00011 - DOI - PubMed
    1. Mori G, Ballini A, Carbone C, Oranger A, Brunetti G, Di Benedetto A, et al. . Osteogenic differentiation of dental follicle stem cells. Int J Med Sci. (2012) 9:480–7. 10.7150/ijms.4583 - DOI - PMC - PubMed
    1. Di Benedetto A, Brunetti G, Posa F, Ballini A, Grassi FR, Colaianni G, et al. . Osteogenic differentiation of mesenchymal stem cells from dental bud: role of integrins and cadherins. Stem Cell Res. (2015) 15:618–28. 10.1016/j.scr.2015.09.011 - DOI - PubMed
    1. Di Benedetto A, Posa F, de Maria S, Ravagnan G, Ballini A, Porro C, et al. . Polydatin, natural precursor of resveratrol, promotes osteogenic differentiation of mesenchymal stem cells. Int J Med Sci. (2018) 15:944–52. 10.7150/ijms.24111 - DOI - PMC - PubMed
    1. Posa F, Di Benedetto A, Colaianni G, Cavalcanti-Adam EA, Brunetti G, Porro C, et al. . Vitamin D effects on osteoblastic differentiation of mesenchymal stem cells from dental tissues. Stem Cells Int. (2016) 2016:9150819. 10.1155/2016/9150819 - DOI - PMC - PubMed

Publication types